NIH-funded research R01 grant

Pancreatic enzyme use to reduce pancreatitis episodes in children

Official title: PAncreatic enzyme USE Reduces the frequency of pancreatitis in children with pancreatic sufficient acute recurrent and chronic pancreatitis

Funded at Research Inst Nationwide Children's Hosp · NIH-11346366 · Data updated 2026-11-12

A study tests whether pancreatic enzyme replacement therapy can cut episodes of pancreatitis and improve quality of life for children with pancreatic-relevant ARP or CP.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionResearch Inst Nationwide Children's Hosp
NIH-funded
Lab location1 site (Columbus, United States)
Project startJuly 6, 2026
Project endMarch 31, 2031
Funding year2026
Award (this year)$822,172
NIH project number1R01DK147528-01
Project IDNIH-11346366 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children with pancreatic sufficient ARP or CP who have prior episodes and can take pancreatic enzyme replacement therapy.

Less likely to help

Some children may not respond to PERT or may have contraindications or tolerability issues.

What this research studies

This project focuses on children with acute recurrent pancreatitis or chronic pancreatitis and investigates whether pancreatic enzyme replacement therapy (PERT) can lower the number of pancreatitis episodes and slow disease progression. The team will conduct pediatric-specific clinical work to determine safety and effectiveness in reducing pain and disruption to daily life, rather than relying on adult data. By enrolling children with ARP or CP and following them over time, researchers aim to generate guidance tailored to pediatric patients and their families. If successful, this approach could lessen hospital visits, improve growth and daily functioning, and inform future treatment options for kids with pancreatic disease.

Why it matters

Potential benefit: If successful, children with ARP or CP may experience fewer pancreatitis episodes and better quality of life.

How similar studies have gone: Existing retrospective data in a small pediatric cohort suggested fewer AP episodes with PERT, but rigorous pediatric trials are needed to confirm benefit.

Where this research is happening

  • Research Inst Nationwide Children's Hosp
    Columbus, United States
    Active

Researchers

  • Principal investigator: Freeman, Alvin Jay — Research Inst Nationwide Children's Hosp
  • Study coordinator: Freeman, Alvin Jay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.